Daniel Rosenberg

Teva to Block Drug for U.S. Execution Use as Hospira Pressured

Teva Pharmaceutical Industries Ltd. said it plans to control distribution of the anesthetic propofol to prevent the drug from being used in executions of U.S. prisoners.

Astellas, Huawei, Formula One: Intellectual Property

A unit of Japan’s Astellas Pharma Inc. sued Hospira Inc., accusing the generic pharmaceutical company of infringing a patent for the drug adenosine, used to diagnose heart blockages.

Hospira, Fresenius Intensify Effort With FDA to Restock Leukemia Medicine

Hospira Inc. , Fresenius SE and Boehringer Ingelheim GmbH are racing to restore U.S. supplies of a leukemia drug while regulators look to imports to meet patient demand.

Lily, Schlumberger, Amazon, HP: Intellectual Property (Updtae1)

Eli Lilly & Co. , already facing competition next year for its top-selling drug, lost a court bid over patent protection on its cancer medicine Gemzar , which could lead to generic products as early as November.

Hospira Rises as CEO Says Drugmaker’s Production Rebounding: Chicago Mover

Hospira Inc., the maker of generic injectable drugs, gained the most in almost five months after the company said a factory cited for manufacturing deficiencies had reopened and was near previous production levels.

Measure to Strengthen Chemical Law Backed by Senate Panel

The Senate Environment and Public Works Committee voted along party lines to approve a measure that would toughen chemical-safety laws overseen by the U.S. Environmental Protection Agency.

Astellas Pharma Sues Hospira Over Patent for Heart-Test Drug

A unit of Japan’s Astellas Pharma Inc. sued Hospira Inc., accusing the generic pharmaceutical company of infringing a patent for the drug adenosine, used to diagnose heart blockages.

Cubist Sues Hospira Over Cubicin Bacteria Medicine Patent

Cubist Pharmaceuticals Inc., a maker of antibiotic medicines, sued Hospira Inc. for patent infringement over plans to market a generic version of Cubicin, a drug used to combat the MRSA flesh-eating bacterium.

Lilly Claim Over Hospira’s Gemzar Copy to Be Reviewed By ITC

Eli Lilly & Co. ’s patent- infringement claim over Hospira Inc. ’s generic version of the cancer treatment Gemzar will be investigated by a U.S. trade agency with the power to block imports of the copycat drug.

Lilly Loses U.S. Appeals Court Ruling Over Patent for Gemzar Cancer Drug

Eli Lilly & Co. , already facing competition next year for its top-selling drug, lost a bid to block generic sales of the cancer medicine Gemzar after November, opening the door to rivals two years earlier than the company anticipated.

"Hospira has long communicated that we do not support the use of any of our products in lethal injection."

- Daniel Rosenberg on Mar 20, 2013

Lake Forest

Washington

New York

Delaware

U.K. to Consider More Curbs on Extremists After Killing

Ferrari Racer at $11.9 Million Beats 1970s Porsche 911s

Merkel Vows to Avert China Trade Dispute as Li Rejects EU Duties

Lesbian Drama Triumphs at Cannes as Douglas Wins Nothing

Stiglitz Says Too Soon to Cut U.S. Stimulus as Growth Not Normal